Purdue University and Elanco Animal Health have broken ground on a One Health Research Institute, launching a university-industry partnership designed to unite human, animal and environmental health research in a single facility.

The announcement, reported by National Hog Farmer, positions the institute within the One Health framework that veterinary medicine, public health agencies and livestock producers have increasingly adopted. The concept recognizes that pathogens, antimicrobial resistance and environmental contaminants move freely among people, production animals, companion animals and wildlife — and that research silos slow the response.

What does the groundbreaking signal for veterinary practice?

For food-animal practitioners, a One Health institute backed by a major animal health company and a land-grant university points research attention toward the problems that surface first in the barn: emerging infectious disease, zoonotic spillover, and antimicrobial stewardship. Purdue's agricultural research tradition and Elanco's commercial portfolio — which spans livestock pharmaceuticals and vaccines — give the partnership direct channels from laboratory findings to products that reach the exam room, the feedlot and the swine barn.

For companion-animal practitioners, One Health infrastructure tends to accelerate work on shared threats such as zoonotic pathogens and resistant infections, areas where small-animal clinics serve as an early surveillance point in the human-animal interface.

Public health agencies, including those tracking foodborne illness and antibiotic resistance, stand to gain from a research hub explicitly structured around cross-species questions rather than single-discipline departments.

Who are the partners?

Purdue University contributes its agricultural and veterinary research base, including a College of Veterinary Medicine with established infectious disease and food-animal programs. Land-grant institutions like Purdue also maintain extension networks that translate research findings into producer-level practice.

Elanco Animal Health, a global animal health company headquartered in Indiana, brings drug and vaccine development capability alongside commercial infrastructure in both livestock and pet health. Elanco has previously framed its corporate strategy around One Health-linked issues, including antimicrobial resistance and protein supply.

Why does location matter?

The institute sits in Indiana, where Elanco maintains its global headquarters and Purdue operates one of the nation's prominent agricultural research universities. Co-location of an industry research institute with a university partner is a model that has produced accelerated translational pipelines in other veterinary and biomedical sectors, shortening the path from basic discovery to licensed products reviewed by regulators such as the FDA's Center for Veterinary Medicine and the USDA.

What questions remain open?

The groundbreaking announcement establishes the partnership and the facility's One Health mission. Details reported so far do not specify the institute's construction timeline, its funding split between the partners, its staffing plan, or the initial research programs it will house. Those specifics will determine how quickly the institute generates findings relevant to practicing veterinarians — and whether its early portfolio leans toward livestock disease, zoonotic surveillance, antimicrobial resistance or companion-animal medicine.

Veterinarians and producers watching the project should look for the first announced research programs and any named principal investigators as indicators of the institute's practical direction. Industry-academic institutes typically publish their initial program slate during construction, well before the facility opens.

As construction proceeds, the institute's first funded studies and its first regulatory filings will show whether this partnership converts the One Health framework into measurable tools — diagnostics, vaccines and therapeutics — that practicing veterinarians can put to work.

Note: This report is based on the groundbreaking announcement. The Vet Scope will update this story as Purdue and Elanco release construction timelines, funding details and research program specifics.